Bringing the fundamentals into focus…
Back to Innate Pharma S.A.
How Innate Pharma S.A. stacks up
IPHA · against 167 other Healthcare companies of similar size
Profitability
1/ 100
Near the bottom of its peers.
Ranked #161 of 168 · scores higher than 2% of peers
Bars: peers in each 10-point band of the profitability score32 peers with a profitability score of 0–9, including IPHA · Click a bar to see the companies
Why profitability scores 1?
Weighted metrics compared with all Healthcare companies.Mainly because of its operating margin and return on assets, which are weaker than most Healthcare peers.
- a thinner operating margin: weaker than 96% of peers. Operating margin: -1916.9% vs peer median 7.1%
- a lower return on assets: weaker than 93% of peers. Return on assets: -46.6% vs peer median 1.7%
- Return on invested capital is not reported, so it is left out of the score.
Metric by metric
Position: dot = IPHA, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | IPHA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 130 reported | Not reported | -5.2% | — | — | 33% |
| Operating marginHigher is better · 152 reported | -1916.9% | 0.1% | 7% | 33% | |
| Return on assetsHigher is better · 172 reported | -46.6% | -2.1% | 13% | 33% | |
| Return on equityHigher is better · 160 reported | Not reported | -5.8% | — | — | Context only |
| Gross marginHigher is better · 179 reported | 0.0% | 40.5% | 7% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around IPHA| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 261M USD | 98 | 97 | |
| 2 | 1.4B HKD (≈$181M) | 97 | 61 | |
| 2 | 356M AUD (≈$235M) | 97 | 81 | |
| 4 | 592M ILS (≈$160M) | 96 | 84 | |
| 5 | 267M USD | 95 | 75 | |
| 158 | 3.4B TWD (≈$106M) | 2 | 36 | |
| 158 | 264M USD | 2 | 24 | |
| 158 | 89M USD | 2 | 31 | |
| 161 | 90M USD | 1 | 27 | |
| 161 | 149M USD | 1 | 10 | |
| 161 | 94M USD | 1 | 8 | |
| 161 | 258M USD | 1 | ||
| 161 | 140M USD | 1 | ||
| 166 | 172M USD | 0 | 3 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score